Media Contact:
Stephen Majors
Head of Global Communications
smajors@alliancerm.org
Washington, DC
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the engineered cell therapy and genetic medicines sector, announced the appointment of Rita Johnson-Greene as Chief Operating Officer, effective April 10.
Washington, DC
Washington, DC
ARM applauds the HHS announcement that the Center for Medicare and Medicaid Innovation (CMMI) will test a “Cell and Gene Therapy Access Model” to administer multi-state outcomes-based agreements in Medicaid programs for transformative cell and gene therapies.
Washington, D.C.
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the cell and gene therapy sector, announced the appointment of Mark Battaglini to the newly created position of Chief Strategy Officer, effective today.
